Sign in

CIK 0001520262 · Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981007018
Phone
00-353-1-772-8000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,070,874
in 5 filings, $1.1M under 10b5-1 plans

Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hopkinson Craig C. −$423K EVP R&D, Chief Medical Officer sold 12% of stake
  2. Nichols Christian Todd −$373K SVP, Chief Commercial Officer sold 7% of stake
  3. Gaffin David Joseph −$275K EVP, CLO, Alkermes, Inc. sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-20 POPS RICHARD F Director and CEO, Alkermes plc Shares withheld for taxes −53,145 $28.07 $1.5M 1,034,867
2023-02-20 Nichols Christian Todd SVP, Chief Commercial Officer Option exercise +3,824 29,128
2023-02-20 Nichols Christian Todd SVP, Chief Commercial Officer Shares withheld for taxes −1,125 $28.07 $32K 28,003
2023-02-20 Nichols Christian Todd SVP, Chief Commercial Officer Grant or award +22,969 50,972
2023-02-20 Nichols Christian Todd SVP, Chief Commercial Officer Shares withheld for taxes −6,753 $28.07 $190K 44,219
2023-02-20 Nichols Christian Todd SVP, Chief Commercial Officer Option exercise · Restricted Stock Unit Award −3,824 3,825
2023-02-20 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Option exercise +5,354 239,956
2023-02-20 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Shares withheld for taxes −2,378 $28.07 $67K 237,578
2023-02-20 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Grant or award +11,770 249,348
2023-02-20 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Shares withheld for taxes −5,226 $28.07 $147K 244,122
2023-02-20 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Option exercise · Restricted Stock Unit Award −5,354 5,354
2023-02-20 Jackson Blair Curtis EVP, Chief Operating Officer Option exercise +4,589 98,543
2023-02-20 Jackson Blair Curtis EVP, Chief Operating Officer Shares withheld for taxes −1,350 $28.07 $38K 97,193
2023-02-20 Jackson Blair Curtis EVP, Chief Operating Officer Grant or award +10,086 107,279
2023-02-20 Jackson Blair Curtis EVP, Chief Operating Officer Shares withheld for taxes −2,966 $28.07 $83K 104,313
2023-02-20 Jackson Blair Curtis EVP, Chief Operating Officer Option exercise · Restricted Stock Unit Award −4,589 4,589
2023-02-20 Hopkinson Craig C. EVP R&D, Chief Medical Officer Option exercise +10,095 34,155
2023-02-20 Hopkinson Craig C. EVP R&D, Chief Medical Officer Shares withheld for taxes −3,780 $28.07 $106K 30,375
2023-02-20 Hopkinson Craig C. EVP R&D, Chief Medical Officer Grant or award +22,195 52,570
2023-02-20 Hopkinson Craig C. EVP R&D, Chief Medical Officer Shares withheld for taxes −6,526 $28.07 $183K 46,044

Page 45 of 60 · 1,194 trades